1093 — CSPC PHARMACEUTICAL Share News
0.000.00%
Last trade - 00:00- HK$96.15bn
- HK$77.27bn
- CNY26.01bn
Brief: Cspc Pharmaceutical Says CSPC Innovation Expects HY Net Profit Of 1.18 Billion-1.36 Billion Yuan
Brief: Cspc Pharmaceutical Says Phase III Trial Of Ha1406 Meets Primary Endpoint
Brief: CSPC Pharmaceutical Expects H1 2026 Profit Attributable RMB5.9 Bln–RMB6.2 Bln
Brief: CSPC Pharmaceutical Says NMPA Accepts New Drug Application For Trastuzumab Envedotin Injection
Brief: Cspc Pharmaceutical Says Docetaxel (Albumin-Bound), Anbenitamab Granted Breakthrough Therapy Designation In China
China's CSPC hits 7-week peak on AstraZeneca tie-up, products progress
Brief: CSPC Pharmaceutical Says Iron Sucrose Injection Receives Marketing Approval In China
Brief: CSPC Pharmaceutical Says SYS6043 Granted Breakthrough Therapy Designation In China For Platinum-Resistant Ovarian Cancer
Brief: Cspc Pharmaceutical's Recombinant Herpes Zoster Vaccine (Sys6052) Obtains Clinical Trial Approval In China
AstraZeneca signs CSPC China deal for experimental kidney disease drugs (updated)
China's CSPC Pharmaceutical Group to partner with AstraZeneca for renal disease drug
Brief: CSPC Pharmaceutical Enters Collaboration, Option & License Agreement With Astrazeneca For siRNA Drugs
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of Sys 6010 With Enlonstobart In China
Brief: CSPC Pharmaceutical Says NMPA Accepts Second Marketing Authorisation Application For Efmedaglutide Alfa Injection
Brief: CSPC Pharmaceutical Says NMPA Accepts Marketing Authorisation Application For Secukinumab Injection
Brief: CSPC Pharmaceutical Says Octreotide Long-Acting Injection Obtains FDA Clinical Trial Approval In U.S
Brief: CSPC Pharmaceutical NMPA Accepts Marketing Authorisation Application For Valsartan, Levamlodipine Maleate Tablets
Brief: CSPC Pharmaceutical Says Paclitaxel For Injection (Albumin-Bound) (Ii) Patented In China, US, And Europe
Alphamab climbs most in over 8 weeks on progress of breast cancer treatment